Differentiated Thyroid Cancer
59
11
17
21
Key Insights
Highlights
Success Rate
81% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
8.5%
5 terminated out of 59 trials
80.8%
-5.8% vs benchmark
14%
8 trials in Phase 3/4
38%
8 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 21 completed trials
Clinical Trials (59)
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Tracheal Replacement Using A Cryopreserved Aortic Allograft For R0 Resection In Locally Advanced Thyroid Cancer (TRITON 02 Tracheal Replacement In ThyrOid caNcer)
Sacituzumab govitEcan in THYroid Cancers
rhTSH for Radioactive Iodine Remnant Ablation in Participants With Differentiated Thyroid Cancer (DTC)
rhTSH for Radioactive Iodine Remnant Ablation in Differentiated Thyroid Cancer
Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated Thyroid Cancer
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection.
Lenvatinib in Locally Advanced Invasive Thyroid Cancer
Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy
Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer.
Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma
Pembrolizumab in High-risk Thyroid Cancer
Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
Empirical Radioactive Iodine Therapy in DTC
F-18 Tetrafluoroborate PET/CT in Differentiated Thyroid Cancer
Radiofrequency in Differentiated Thyroid Cancer Metastatic Lymph Node: Prospective Study of Safety and Efficacy
Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy